Transforming Enterprise Operations Through Unified Technology Architecture for a Leading Global Healthcare Conglomerate

Key challenges
Outdated technology infrastructure was limiting operational efficiency and scalability across the enterprise — creating a growing gap between the demands of a multinational operation spanning 250 subsidiary companies across 57 countries and the capability of the systems expected to support it. The existing technology foundation had not kept pace with the scale and complexity of the business, leaving critical operational functions — from inventory management to order processing — running on infrastructure that was increasingly unable to deliver the performance and reliability a global healthcare conglomerate required.
Integration complexities with legacy systems were impacting seamless data flow and process continuity across the enterprise. In an organization of this scale, where operations span multiple subsidiaries, geographies, and business functions, fragmented systems and broken data flows translate directly into operational blind spots — creating situations where inventory levels, order statuses, and procurement data were inconsistent or inaccessible across the functions that depended on them to make time-sensitive decisions.
A comprehensive architecture revamp was needed to support the full breadth of a multinational operation spanning 250 subsidiary companies — one that could unify enterprise integration, warehouse management, and product inventory visibility into a single, coherent technology foundation. Without a modernized architecture capable of supporting this scale, the organization risked continued operational fragmentation as its global footprint expanded and the demands on its enterprise systems continued to grow.
Client in spotlight
The Janssen Pharmaceutical Companies, acquired by Johnson & Johnson are dedicated to addressing and solving the most important unmet medical needs of our time, including oncology, immunology, neuroscience, infectious disease, and cardiovascular and metabolic diseases. Driven by commitment to patients, they develop sustainable, integrated healthcare solutions by working side-by-side with healthcare stakeholders based on partnerships of trust and transparency.

Unlocking Digital success



Project outcomes
Faster setup of trial sites and reduction in operational delays led to smoother clinical trial workflows
Centralized setup linking of organizations and contacts ensured data accuracy across trial sites
Reducing manual administrative tasks allowed Johnson & Johnson’s internal teams to allocate more resources toward research and strategic initiatives
Download Success Story
Dive deeper into the complete solution. Access the detailed success story in the PDF.
